OSSIO
-
Extremities
OSSIO Launches World’s First and Only Non-Permanent Compression Staple
OSSIOfiber® Compression Staple Answers Surgeon, Patient Demand in Fastest Growing Product Category in Extremities February 7, 2023 WOBURN, Mass.–(BUSINESS WIRE)– OSSIO, Inc.,…
Read More » -
Financial
OSSIO Closes Series C Financing of $38.5 Million
Proceeds will be used to strengthen awareness for the patient benefits of bio-integrative OSSIOfiber® implants and accelerate new product platforms into the major…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology
Indications for Use Include Surgery on Foot/Ankle, Shoulder, Knee, Hand/Wrist and Elbow Advantages Over Traditional Anchors Include Self-Tapping Insertion Strength, Superior Pull-Out…
Read More » -
Regulatory
OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3
New Suture Anchors, Industry’s First U.S.-Cleared Non-Permanent Compression Staples and Additional Compression Screws to Join Previously Launched Products That Leave…
Read More » -
Biologics
OSSIO Appoints Gregory C. Berlet, MD, as Chief Medical Officer
November 2, 2021 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation technology company, today announced the appointment of Gregory C. Berlet,…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of the Bio-Integrative OSSIOfiber®Compression Screw Portfolio
Company Secures $20 Million in Financing to Accelerate Product Development & Advance Commercialization WOBURN, Mass. – OSSIO, Inc., an orthopedic…
Read More » -
Extremities
OSSIO Awarded FDA 510(k) Clearance for OSSIOfiber® Compression Screw Portfolio
Company Successfully Surpasses 1,000th Implantation Milestone for its Strong and Bio-integrative OSSIOfiber® Technology WOBURN, Mass., October 19, 2020– OSSIO, Inc.,…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of the OSSIOfiber® Trimmable Fixation Nail System for Broad Utilization in Foot/Ankle and Hand/Wrist Procedures
July 22, 2020 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation company, today announced the U.S. launch and first commercial use…
Read More » -
Extremities
OSSIO Receives FDA 510(k) Clearance for OSSIOfiber® Hammertoe Fixation System
March 12, 2020 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber® Hammertoe Fixation System has…
Read More » -
Extremities
OSSIO Receives Prestigious Frost & Sullivan New Product Innovation Award for OSSIOfiberTM Intelligent Bone Regeneration Technology
Woburn, Mass., June 11, 2019 – OSSIO, Inc., an orthopedic fixation company, announced today that its OSSIOfiberTM Intelligent Bone Regeneration…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of the New OSSIOfiberTM Bone Pin for Hammertoe Correction
May 16, 2019 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation company, today announced the U.S. launch and first commercial use…
Read More »